Antigenic quantities of fetal blood cells enter the maternal circulation of mice only during delivery, and thus anti-KEL antibodies become measurable in the postpartum period and elicit a disease resembling HDFN in subsequent KEL+ gestations (Stowell et al., 2013). The gene discussed is KEL; the disease is fetal erythroblastosis.